Vascular endothelial growth factor-B is neuroprotective in an in vivo rat model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neuroscience Letters

• Publication date

  2011-05-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.neulet.2011.03.088PMID 21507340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurodegeneration and neuroprotection in Parkinson disease

  2011cited by this paper
• The Yin and Yang of VEGF and PEDF: Multifaceted Neurotrophic Factors and Their Potential in the Treatment of Parkinson’s Disease

  2010cited by this paper
• The scientific and clinical basis for the treatment of Parkinson disease (2009)

  2009cited by this paper
• Mesencephalic Astrocyte-Derived Neurotrophic Factor Is Neurorestorative in Rat Model of Parkinson's Disease

  2009cited by this paper
• Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease.

  2009cited by this paper
• Targets for neuroprotection in Parkinson's disease.

  2009cited by this paper
• Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease

  2009cited by this paper
• VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats.

  2008cited by this paper
• Activation of the extracellular signal‐regulated kinases 1 and 2 by glial cell line‐derived neurotrophic factor and its relation to neuroprotection in a mouse model of Parkinson's disease

  2008cited by this paper
• What causes cell death in Parkinson's disease?

  2008cited by this paper
• Novel Role for Vascular Endothelial Growth Factor (VEGF) Receptor-1 and Its Ligand VEGF-B in Motor Neuron Degeneration

  2008cited by this paper
• Treatment of Parkinson’s disease with trophic factors

  2008cited by this paper
• Favorable effects of VEGF gene transfer on a rat model of Parkinson disease using adeno-associated viral vectors.

  2007cited by this paper
• Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo

  2007cited by this paper
• Blood–brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons

  2007cited by this paper
• Behavioral tests for preclinical intervention assessment

  2006cited by this paper
• Biology of vascular endothelial growth factors

  2006cited by this paper
• Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration.

  2006cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• Toxin-induced models of Parkinson’s disease

  2005cited by this paper
• New roles for VEGF in nervous tissue--beyond blood vessels.

  2004cited by this paper
• Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

  2004cited by this paper
• Increased Severity of Cerebral Ischemic Injury in Vascular Endothelial Growth Factor-B–Deficient Mice

  2004cited by this paper
• Neurodegeneration and neuroprotection in Parkinson disease

  2004cited by this paper
• Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells.

  2003cited by this paper
• The GDNF family: Signalling, biological functions and therapeutic value

  2002cited by this paper
• Genomic Organization of the Mouse and Human Genes for Vascular Endothelial Growth Factor B (VEGF-B) and Characterization of a Second Splice Isoform*

  1996cited by this paper
• Neurodegeneration and Neuroprotection in Parkinson's Disease

  1996cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983cited by this paper

• TLR3 activation in astrocytes attenuates the nigrostriatal pathway degeneration in rodent models of Parkinson's disease.

  2026cites this paper
• Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure

  2025cites this paper
• Association of 10 VEGF Family Genes with Alzheimer’s Disease Endophenotypes at Single Cell Resolution

  2024cites this paper
• From central to peripheral: A new perspective on bladder dysfunction in Parkinson disease

  2024cites this paper
• Gene Therapy for Parkinson’s Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance

  2024cites this paper
• The VEGFs/VEGFRs system in Alzheimer's and Parkinson's diseases: pathophysiological roles and therapeutic implications.

  2024cites this paper
• Association of ten VEGF family genes with Alzheimer's disease endophenotypes at single cell resolution

  2024cites this paper
• Multi-omic characterization of brain changes in the vascular endothelial growth factor family during aging and Alzheimer's disease.

  2023cites this paper
• Neuroprotective Effects of VEGF-B in a Murine Model of Aggressive Neuronal Loss with Childhood Onset

  2023cites this paper
• Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin‐1

  2021cites this paper
• Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats

  2021cites this paper
• Reversing Parkinson Disease Model with in situ Converted Nigral Neurons

  2020cites this paper
• Therapeutic Reversal of Chemically Induced Parkinson Disease by Converting Astrocytes into Nigral Neurons

  2020cites this paper
• Neurotrophic effects of vascular endothelial growth factor B and novel mimetic peptides on neurons from the central nervous system.

  2020cites this paper
• Reversing a model of Parkinson's disease with in situ converted nigral neurons.

  2020cites this paper
• Stepwise Protocols for Converting Astrocytes to Neurons in vitro and in Mouse Brain by Depleting Polypyrimidine Tract Binding Protein PTB

  2020cites this paper
• PHYSICAL ACTIVITY–INDUCED NEUROPROTECTION IN PARKINSON’S DISEASE IS MEDIATED BY NEUROTROPHIC FACTORS

  2020cites this paper
• The Effects of Deep Brain Stimulation of the Subthalamic Nucleus on Vascular Endothelial Growth Factor, Brain-Derived Neurotrophic Factor, and Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson’s Disease

  2020cites this paper
• Immunotherapies in Huntington's disease and α-Synucleinopathies

  2020cites this paper
• Novel function of VEGF‐B as an antioxidant and therapeutic implications

  2019cites this paper
• Differential effects of neural stem cell therapy in adult and middle-aged parkinsonian mice

  2019cites this paper
• Neuroprotection by Heat Shock Factor-1 (HSF1) and Trimerization-Deficient Mutant Identifies Novel Alterations in Gene Expression

  2018cites this paper
• Long-Term Intravitreal Ranibizumab as a Potential Additional Risk Factor for Neurodegeneration in Parkinson’s Disease: A Case Report

  2018cites this paper
• Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease

  2018cites this paper
• Anti-VEGF treatment improves neurological function in tumors of the nervous system.

  2018cites this paper
• Preliminary Studies of Edible Bird Nest ( EBN ) Extract Reduced H 1 N 1 Virus Induced Apoptosis on Cultured Cells-In Vitro

  2017cites this paper
• Is VEGF a Key Target of Cotinine and Other Potential Therapies Against Alzheimer Disease?

  2017cites this paper
• Glutamate Neonatal Excitotoxicity Modifies VEGF-A, VEGF-B, VEGFR-1 and VEGFR-2 Protein Expression Profiles During Postnatal Development of the Cerebral Cortex and Hippocampus of Male Rats

  2017cites this paper
• VEGF Receptor Tyrosine Kinases: Key Regulators of Vascular Function.

  2017cites this paper
• Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons

  2017cites this paper
• Vascular endothelial growth factor-B: Impact on physiology and pathology

  2017cites this paper
• Vascular endothelial growth factor: a neurovascular target in neurological diseases

  2016cites this paper
• Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia–reperfusion injury

  2016cites this paper
• Association of RAGE gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.

  2016cites this paper
• Association of VEGF gene polymorphisms with sporadic Parkinson’s disease in Chinese Han population

  2016cites this paper
• The Evaluation of Cell Death Reduction of Cultured Infected Cells by H1N1 Virus with Edible Bird Nest (EBN) Extract in-vitro Study

  2016cites this paper
• The evaluation of Edible Bird Nest (EBN) Extract Reduced Influenza A virus Induced Apoptosis on Cultured Cells in vitro study

  2016cites this paper
• PLGA Nano- and Microparticles for VEGF Delivery

  2016cites this paper
• Intranasal gene delivery for treating Parkinson’s disease: overcoming the blood–brain barrier

  2015cites this paper
• Edible bird’s nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells

  2014cites this paper
• Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.

  2014influential citation
• Avaliação dos efeitos da variabilidade da pressão arterial sistêmica sobre a pressão de perfusão ocular e suas repercussões sobre o estresse oxidativo em retinas de ratos normotensos e hipertensos

  2014cites this paper
• Defining Best Practice Standards for the Diagnosis and Management of Diabetic Retinopathy and Diabetic Macular Edema in Latin America

  2014cites this paper
• Vascular endothelial growth factor-B in physiology and disease.

  2014cites this paper
• The restorative effect of intramuscular injection of tetanus toxin C-fragment in hemiparkinsonian rats.

  2014cites this paper
• Stem Cell Therapy for Neurodegenerative Diseases

  2014cites this paper
• VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions

  2014cites this paper
• Hypoxia modulates the differentiation potential of stem cells of the apical papilla.

  2014cites this paper
• Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.

  2014cites this paper
• VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration

  2013cites this paper
• Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia.

  2013cites this paper
• Neurobiology of Parkinson's Disease Gene Pink1 in Danio rerio (Zebrafish)

  2013cites this paper
• Chronic exposure of astrocytes to interferon-α reveals molecular changes related to Aicardi-Goutieres syndrome.

  2013cites this paper
• Brain homeostasis: VEGF receptor 1 and 2—two unequal brothers in mind

  2013cites this paper
• Complicated life, complicated VEGF-B.

  2012cites this paper
• Effects of the novel glycopeptide opioid agonist MMP-2200 in preclinical models of Parkinson's disease.

  2011cites this paper
• Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo.

  2011influential citation
• Can VEGF-B Be Used to Treat Neurodegenerative Diseases?

  2011cites this paper
• Association of 10 VEGF Family Genes with Alzheimer’s Disease Pathology at Single Cell 1

  year unknowncites this paper